Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
2.090
-0.290 (-12.18%)
Nov 20, 2024, 4:00 PM EST - Market open
Adagene Market Cap
Adagene has a market cap or net worth of $97.84 million as of November 21, 2024. Its market cap has increased by 65.33% in one year.
Market Cap
97.84M
Enterprise Value
17.64M
1-Year Change
65.33%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $97.84M, a decrease of -87.83%. That is a compound annual growth rate of -42.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 92.53M | 9.29% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Journey Medical | 104.67M |
| Akoya Biosciences | 103.59M |
| InflaRx | 102.46M |
| Assembly Biosciences | 100.65M |
| Karyopharm Therapeutics | 99.56M |
| Fractyl Health | 99.08M |
| Seres Therapeutics | 98.53M |
| Anixa Biosciences | 98.15M |